CL和Uroplasty公司几种泌尿科新产品推向市场

 
一种生物兼容聚丙烯的无压力中尿道悬带，被设计用于治疗女性小便失禁。该悬带已经获得了美国食品药品管理局的许可。

这种尿道悬带是CL医疗器械公司(Lyon, France)的产品，已经成功投放欧洲市场。根据CL公司的一项排他性协议，Uroplasty公司(Minneapolis, MN, USA)正在美国和英国市场制造这种悬带，并将一种叫做I-STOP的设备推向市场。

Uroplasty已经研发或者正在研发几种用于治疗排泄功能障碍的其他产品。这包括急症PC神经调制系统，一种创伤性很小的神经刺激设备，用于在办公室治疗急症小便失禁的膀胱过度活跃症状以及尿频尿急。Macroplastique是另外一种泌尿科产品，为男性和女性小便失禁患者提供可移植的软组织罐装产品。当把Macroplastique注射入尿道周围组织，就能够稳定和“罐装”尿道周围的组织，提高周围肌肉的功能控制尿液的排泄。

Sling to Treat Female Incontinence
 
A biocompatible polypropylene, tension-free, mid-urethral sling is designed for the treatment of incontinence in women. The sling has been cleared by the U.S. Food and Drug Administration (FDA).

The product of CL Medical (Lyon, France), the sling has been successfully launched in European markets. Under an exclusive agreement with CL Medical, Uroplasty, Inc. (Minneapolis, MN, USA) is manufacturing the sling and marketing the device, called I-STOP, in the United States and the United Kingdom.

Uroplasty has developed or is developing several other products for voiding dysfunction. These include the Urgent PC neuromodulation system that is a minimally invasive nerve stimulation device for office-based treatment of overactive bladder symptoms of urge incontinence and urinary urgency and frequency. Macroplastique implants, another Uroplasty product, offer an implantable soft tissue bulking product for both male and female incontinence. When Macroplastique is injected into tissue around the urethra, it stabilizes and “bulks” tissues close to the urethra, providing the surrounding muscles with increased capability to control the release of urine.